As 2020 winds down, we want to look to the year ahead. In this minisode, we sit down with Vynamic’s Life Sciences Sector Advisor, Karen Baldry, to discuss the trends she sees being the most impactful in 2021. The episode opens with a discussion of the COVID-19 vaccine and the shift in focus from clinical trials to supply, distribution, pricing, and access (01:15). Even after a vaccine is available, life sciences organizations will likely still see long term impacts of the pandemic across the business (01:52), with digital becoming an increasing area of concentration and innovation (02:15). The conversation then moves to the impact of these trends (03:00), including changes to future vaccine and drug development, interactions with HCPs (04:05), and investment in omnichannel (5:04). The interview closes with the hope that learnings from 2020 unlock new opportunities for life sciences companies and organizations across the entire healthcare industry (6:09).
Podcast
Spotlight Trends Minisode: Life Sciences
Related Content
MedTech Goes Digital
Trending News EU – 11 May 2023
Trending News US – May 4, 2023
DEI & You – Overcoming Data Biases to Advance Health Equity
Trending News US – April 20, 2023
Trending News EU – 13 April 2023
Life Sciences, Health Systems, and Healthcare Tech: Working Together to Deliver Better Patient Outcomes
What if there was a digital tool that could close the loop between patient and provider, using data to improve diagnosis and treatment? Read how Vynamic addressed that question for a Life Sciences client by providing the leadership to make this concept a reality.
- Sectors:
- Life Sciences
- Providers
- Healthcare Technology
Establishing an Agile Commercial Innovation Hub for a Big Pharma That Wants to Operate More Like Healthcare Tech
A global Life Sciences company wanted to reinvent its commercial business model and disrupt the overall healthcare industry by operating more like a nimble biotech. To do so, the company engaged with Vynamic to develop an innovation capability that would allow it to run agile experiments and quickly learn from both the successes and failures while identifying potential solutions. Read how Vynamic established the value proposition, framework, and team structure to enable this innovative capability, while also providing the overall program monitoring and control.
- Sectors:
- Life Sciences
- Services:
- Operating Model & Org Design©
Market Access Capability Analysis & Process Mapping for a Cell and Gene Therapy Biotech
A pre-commercial Cell and Gene Therapy client was preparing for the launch of its first product. Read how the newly formed Market Access team contacted Vynamic to assist with strategic planning and process development to support an innovative, outcomes-driven approach for value based contracting arrangements.
- Sectors:
- Life Sciences
Want to learn more? Get in Touch!
Contact our team to learn more about how we can help your needs.